Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Joshua Barocas to Adolescent

This is a "connection" page, showing publications Joshua Barocas has written about Adolescent.

 
Connection Strength
 
 
 
0.634
 
  1. Guan X, Jurecka C, Padmanabhan P, Yamkovoy K, Christine PJ, Binswanger IA, Glanz JM, Kline DM, Barocas JA. Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in Colorado. Int J Drug Policy. 2025 12; 146:105037.
    View in: PubMed
    Score: 0.059
  2. Jurecka C, Adams J, Padmanabhan P, Glanz J, Christine P, Guan X, Kline D, Binswanger I, Barocas J. Implementation of a Statewide Fentanyl Possession Law and Opioid-Related Overdose Deaths. JAMA Health Forum. 2025 Aug 01; 6(8):e252654.
    View in: PubMed
    Score: 0.058
  3. Westfall MY, Padmanabhan P, Wang J, Nall SK, Stella SA, Kushel M, Belcher C, Davis L, Versen E, LeBeouf W, Barocas JA. Youth Homelessness in Denver, Colorado: 2017-2021. Pediatrics. 2025 Feb 01; 155(2).
    View in: PubMed
    Score: 0.056
  4. Barocas JA, Erdman EA, Westfall MY, Christine PJ, Bernson D, Villani J, Doogan NJ, White L, Walley AY, Bettano A, Wang J. Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014-2021. Addiction. 2025 Apr; 120(4):711-720.
    View in: PubMed
    Score: 0.055
  5. Calcaterra SL, Yamkovoy K, Swathi PA, Ciccarone D, Del Pozo B, Englander H, Wang J, Barocas JA. U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019. Drug Alcohol Depend. 2024 09 01; 262:111409.
    View in: PubMed
    Score: 0.054
  6. Barocas JA, Gai MJ, Nurani A, Bagley SM, Hadland SE. Initiation of HIV pre-exposure prophylaxis among youth in the United States, 2015-2018. AIDS Care. 2023 03; 35(3):431-436.
    View in: PubMed
    Score: 0.046
  7. Hadland SE, Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Morgan JR, Barocas JA. Opioid use disorder and overdose among youth following an initial opioid prescription. Addiction. 2021 10; 116(10):2790-2800.
    View in: PubMed
    Score: 0.043
  8. Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Hadland SE, Barocas JA. Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by Sex. JAMA Netw Open. 2020 12 01; 3(12):e2030201.
    View in: PubMed
    Score: 0.042
  9. Barocas JA, Gai MJ, Amuchi B, Jawa R, Linas BP. Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections. Drug Alcohol Depend. 2020 10 01; 215:108207.
    View in: PubMed
    Score: 0.041
  10. Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, Beckwith CG, Linas BP, Walley AY. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019 07 01; 200:59-63.
    View in: PubMed
    Score: 0.037
  11. Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 12; 108(12):1675-1681.
    View in: PubMed
    Score: 0.036
  12. Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 08 01; 67(4):549-556.
    View in: PubMed
    Score: 0.035
  13. Barocas JA, Brennan MB, Hull SJ, Stokes S, Fangman JJ, Westergaard RP. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study. Harm Reduct J. 2014 Jan 14; 11:1.
    View in: PubMed
    Score: 0.026
  14. Dowd WN, Chen Q, Barbosa C, Sahinkoc HM, Barocas J, Chhatwal J, Aldridge AP, Zarkin GA, Knudsen AB. Estimating community-level prevalence of opioid use disorder: Extrapolating from Medicaid claims data and other publicly available data sources in Ohio, USA. Addiction. 2026 Apr; 121(4):944-954.
    View in: PubMed
    Score: 0.015
  15. Zheng T, Keyes K, Ji S, Calderon A, Wu E, Doogan NJ, Villani J, Chandler R, Barocas JA, Nguyen T, El-Bassel N, Feaster DJ. Opioid use disorder prevalence in 57 New York counties from 2017 to 2019: A Bayesian evidence synthesis. Drug Alcohol Depend. 2025 02 01; 267:112548.
    View in: PubMed
    Score: 0.014
  16. Min JE, Pearce LA, Homayra F, Dale LM, Barocas JA, Irvine MA, Slaunwhite AK, McGowan G, Torban M, Nosyk B. Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis. Drug Alcohol Depend. 2020 12 01; 217:108337.
    View in: PubMed
    Score: 0.010
  17. Bauer CL, Victorson D, Rosenbloom S, Barocas J, Silver RK. Alleviating distress during antepartum hospitalization: a randomized controlled trial of music and recreation therapy. J Womens Health (Larchmt). 2010 Mar; 19(3):523-31.
    View in: PubMed
    Score: 0.005
  18. Lai JS, Cella D, Peterman A, Barocas J, Goldman S. Anorexia/cachexia-related quality of life for children with cancer. Cancer. 2005 Oct 01; 104(7):1531-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)